Mirae Asset Global ETFs Holdings
SMMT icon

Mirae Asset Global ETFs Holdings’s Summit Therapeutics SMMT Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio SMMT Stock Details SMMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$312K Buy
18,357
+1,497
+9% +$24.2K ﹤0.01% 2126
2025
Q4 		$295K Sell
16,860
-1,136
-6% -$21.4K ﹤0.01% 2163
2025
Q3 		$380K Buy
17,996
+7,685
+75% +$186K ﹤0.01% 2003
2025
Q2 		$213K Sell
10,311
-55,100
-84% -$1.26M ﹤0.01% 2251
2025
Q1 		$1.27M Buy
65,411
+694
+1% +$13.9K ﹤0.01% 1375
2024
Q4 		$1.16M Buy
64,717
+12,546
+24% +$243K ﹤0.01% 1476
2024
Q3 		$1.14M Sell
52,171
-12,647
-20% -$177K ﹤0.01% 1466
2024
Q2 		$506K Buy
+64,818
New +$350K ﹤0.01% 1820

Other funds holding SMMT

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
UBS Group
UBS Group Zurich, Switzerland $564B AUM 30.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return